0001181431-12-007983.txt : 20120213 0001181431-12-007983.hdr.sgml : 20120213 20120213063305 ACCESSION NUMBER: 0001181431-12-007983 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120201 FILED AS OF DATE: 20120213 DATE AS OF CHANGE: 20120213 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FERRARI LOUIS CENTRAL INDEX KEY: 0001513697 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15313 FILM NUMBER: 12595112 MAIL ADDRESS: STREET 1: 765 WARREN STREET CITY: WARRREN STREET STATE: NJ ZIP: 07090 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000722104 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 133033811 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 BUSINESS PHONE: 7324189300 MAIL ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 FORMER COMPANY: FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP DATE OF NAME CHANGE: 19920703 4 1 rrd333865.xml X0304 4 2012-02-01 0 0000722104 SAVIENT PHARMACEUTICALS INC SVNT 0001513697 FERRARI LOUIS SAVIENT PHARMACEUTICALS, INC. ONE TOWER CENTER, 14TH FLOOR EAST BRUNSWICK NJ 08816 0 1 0 0 EVP, N American Commerical Ops Common Stock, $.01 par value per share 2012-02-01 4 A 0 310000 2.26 A 354603 D Common Stock, $.01 par value per share 2011-11-30 4 A 0 381 2.13 A 44603 D Common Stock, $.01 par value per share 2011-08-31 4 A 0 222 3.66 A 44222 D Option to Purchase Common Stock, $.01 par value 2.26 2012-02-01 4 A 0 100000 2.26 A 2013-02-01 2022-02-01 Common Stock, $.01 par value per share 100000 100000 D The right to receive these shares is pursuant to a restricted stock grant that vests as to 50% on each of the first and second anniversaries of the grant date, provided that the grantee remains employed by the Company on these dates. Consists of shares acquired pursuant to the Savient Pharmaceuticals, Inc. 1998 Employee Stock Purchase Plan, which were not previously reported. These options vest as to 25% on each of the first four anniversaries of the grant date, provided that the grantee remains employed by the Company on these dates. /s/ Irina Ishak for Louis Ferrari 2012-02-13